Latest chronic pancreatitis Stories
ABBOTT PARK, Ill.., May 3 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced that the U.S.
SILVER SPRING, Md., April 12 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Pancreaze Delayed Release Capsules, a pancreatic enzyme product (PEP).
MARIETTA, Ga., Feb. 5 /PRNewswire-FirstCall/ -- Solvay Pharmaceuticals, Inc.
MARIETTA, Ga., Oct. 26 /PRNewswire/ -- Solvay Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 19 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) reported today that it has completed patient treatment in its Phase 3 clinical trial of RG1068, synthetic human secretin, in magnetic resonance imaging (MRI) of the pancreas.
MARIETTA, Ga., Oct. 15 /PRNewswire/ -- Solvay Pharmaceuticals, Inc.
MARIETTA, Ga., Oct. 9 /PRNewswire/ -- Solvay Pharmaceuticals, Inc.
Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer.
MARIETTA, Ga., July 7 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. today announced the commercial availability of CREON(R) (pancrelipase) Delayed-Release Capsules.
U.S. researchers found a minority of acute or chronic pancreatic patients are heavy drinkers.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.